Browsing Tag
pivotal Phase III trial
1 post
Newron and EA Pharma secure landmark licensing deal to advance schizophrenia treatment
In a move set to transform treatment options for patients with schizophrenia, Newron Pharmaceuticals S.p.A. (“Newron”) has entered…